Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026.
The company will host a conference call at 8:00 a.m. ET that day; participants should pre-register to receive dial-in details and a unique PIN. A live webcast will be available at investors.fortrea.com, with a replay posted in Events and Presentations after the call.
Positive
- None.
Negative
- None.
News Market Reaction – FTRE
In the Apr 21 session, FTRE declined 1.15%, reflecting a mild negative market reaction. Argus tracked a trough of -9.2% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 29 | Earnings date set | Neutral | +1.9% | Announced Q4 and full-year 2025 results date and conference call details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date scheduling news saw a modest positive move of 1.91%, hinting that these logistical updates can coincide with a slightly constructive tone.
Over recent months, Fortrea has combined operational updates with financial milestones. On Jan 29, 2026, it announced the Q4 and full-year 2025 earnings date and call logistics, which preceded formal 2025 results on Feb 26, 2026 detailing revenue of $2,723.4M, a GAAP net loss driven by a large goodwill impairment, and 2026 revenue and EBITDA guidance. The current Q1 2026 earnings-date announcement continues this pattern of structured communication around periodic results.
Key Terms
contract research organization (CRO) medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results.
To participate in the conference call, participants should pre-register via the call registration link. All registrants will receive dial-in details and a unique PIN providing access to the live call. To avoid potential delays, participants are encouraged to join at least 10 minutes prior to the start of the call.
The live webcast can be accessed at investors.fortrea.com. A replay will be available in the Events and Presentations section of the site following the conclusion of the call.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team, operating across approximately 100 countries, is scaled to deliver focused, agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com